Related Experiment Video
Updated: Jul 15, 2026

08:30
MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
Published on: May 16, 2012
Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels
B Muralidhar1, L D Goldstein, G Ng
1Medical Research Council Cancer Cell Unit, Cambridge, CB2 0XZ, UK.
The Journal of Pathology
|May 2, 2007
Summary
Gain of chromosome 5p in cervical cancer leads to increased Drosha expression, a key microRNA processor. This suggests Drosha and microRNA alterations contribute to cancer progression and invasiveness.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Chromosome 5p gain is frequent in advanced cervical squamous cell carcinomas (SCCs).
- The specific genes driving the advantage from 5p gain are not well understood.
- MicroRNAs (miRNAs) play crucial roles in cellular processes, including cancer development.
Purpose of the Study:
- To investigate the role of 5p gain in cervical carcinogenesis.
- To identify genes responsible for the selective advantage conferred by 5p gain.
- To explore the functional significance of Drosha overexpression in cervical SCC.
Main Methods:
- Utilized the W12 cervical carcinogenesis model for in vitro studies.
- Analyzed copy-number and transcript levels of miRNA processing genes in clinical SCC samples and cell lines.
- Performed global miRNA profiling and principal component analysis.
Main Results:
- 5p gain rapidly conferred a growth advantage and invasiveness in the W12 model.
- Drosha, a miRNA processor, was the most upregulated transcript following 5p gain.
- Drosha copy-number gain and overexpression were observed in clinical cervical SCC, correlating with copy number, but not in pre-malignant lesions.
- Drosha overexpression significantly impacted miRNA profiles, with associated miRNAs implicated in carcinogenesis.
Conclusions:
- Copy-number driven Drosha overexpression, leading to altered miRNA profiles, is a likely contributor to the selective advantage of 5p gain in cervical neoplastic progression.
- Drosha and its downstream miRNA effects are functionally significant in cervical SCC.
- Targeting Drosha or its miRNA pathways may offer therapeutic strategies for cervical cancer.
Related Concept Videos
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...

